Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1977 Oct;74(10):4605–4609. doi: 10.1073/pnas.74.10.4605

Antigen-specific purification of blocking factors from sera of mice with chemically induced tumors.

J T Nepom, I Hellström, K E Hellström
PMCID: PMC431995  PMID: 73182

Abstract

Serum from mice with growing tumors can prevent ("block") the destruction of tumor cells by immune lymphocytes, as measured in a microcytotoxicity assay. Factors responsible for this blocking activity were purified by binding to immune adsorbents that had been prepared from antibodies obtained by immunizing BALB/c mice to the homologous tumors. Two transplantable BALB/c sarcoma lines with individually different tumor-specific transplantation antigens were studied in parallel. The original tumor-specific blocking activity was recovered by elution of the immune adsorbents; that is, (i) eluates blocked the reduction of surviving tumor cell targets by immune lymphocytes only if the tumor specificity, and (ii) immune adsorbent columns prepared from tumor-immune sera recognized the purified blocking fractions in a tumor-specific fashion, indicating that a portion of the humoral response in the immune mice was directed against a factor that was individually distinct for each tumor. Absorption of eluates with the homologous tumor cells removed their blocking activity, indicating that the blocking factors have antigen-binding properties. Blocking activity in the purified fractions resided in molecules presumptively identified as glycoproteins by affinity chromatography on concanavalin A-Sepharose.

Full text

PDF
4605

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin R. W., Price M. R., Robins R. A. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes. Nat New Biol. 1972 Aug 9;238(84):185–186. doi: 10.1038/newbio238185a0. [DOI] [PubMed] [Google Scholar]
  2. Baldwin R. W., Price M. R. Tumor antigens and tumor-host relationships. Annu Rev Med. 1976;27:151–163. doi: 10.1146/annurev.me.27.020176.001055. [DOI] [PubMed] [Google Scholar]
  3. Cooperband S. R., Badger A. M., Davis R. C., Schmid K., Mannick J. A. The effect of immunoregulatory globulin (IRA) upon lymphocytes in vitro. J Immunol. 1972 Jul;109(1):154–163. [PubMed] [Google Scholar]
  4. Hellström I., Hellström K. E., Sjögren H. O. Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas. Cell Immunol. 1970 May;1(1):18–30. doi: 10.1016/0008-8749(70)90058-4. [DOI] [PubMed] [Google Scholar]
  5. Hellström I., Hellström K. E. Studies on cellular immunity and its serum mediated inhibition in Moloney-virus-induced mouse sarcomas. Int J Cancer. 1969 Sep 15;4(5):587–600. doi: 10.1002/ijc.2910040503. [DOI] [PubMed] [Google Scholar]
  6. Hellström K. E., Hellström I. Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol. 1974;18:209–277. doi: 10.1016/s0065-2776(08)60311-9. [DOI] [PubMed] [Google Scholar]
  7. Kapp J. A., Pierce C. W., De la Croix F., Benacerraf B. Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT). J Immunol. 1976 Feb;116(2):305–309. [PubMed] [Google Scholar]
  8. Nelson K., Pollack S. B., Hellström K. E. Specific anti-tumor responses by cultured immune spleen cells. I. In vitro culture method and initial characterization of factors which block immune cell-mediated cytotoxicity in vitro. Int J Cancer. 1975 May 15;15(5):806–814. doi: 10.1002/ijc.2910150512. [DOI] [PubMed] [Google Scholar]
  9. Nelson K., Pollack S. B., Hellström K. E. Specific anti-tumor responses of cultured immune spleen cells III. Further characterization of cells which synthesize factors with blocking and antiserum-dependent cellular cytotoxic (ADC) activities. Int J Cancer. 1975 Oct 15;16(4):539–549. doi: 10.1002/ijc.2910160404. [DOI] [PubMed] [Google Scholar]
  10. Nepom J. T., Hellström I., Hellström K. E. Purification and partial characterization of a tumor-specific blocking factor from sera of mice with growing chemically induced sarcomas. J Immunol. 1976 Nov;117(5 PT2):1846–1852. [PubMed] [Google Scholar]
  11. Tada T., Taniguchi M., Takemori T. Properties of primed suppressor T cells and their products. Transplant Rev. 1975;26:106–129. doi: 10.1111/j.1600-065x.1975.tb00177.x. [DOI] [PubMed] [Google Scholar]
  12. Tamerius J., Nepom J., Hellström I., Hellström K. E. Tumor-associated blocking factors: isolation from sera of tumor-bearing mice. J Immunol. 1976 Mar;116(3):724–730. [PubMed] [Google Scholar]
  13. Waksman B. H., Namba Y. On soluble mediators of immunologic regulation. Cell Immunol. 1976 Jan;21(1):161–176. doi: 10.1016/0008-8749(76)90337-3. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES